Correction: Predictive Biomarkers for Disease Sensitivity in Lymphoma – The Holy Grail for HDAC Inhibitors?
Oncotarget - United States
doi 10.18632/oncotarget.26767
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 26, 2019
Authors
Publisher
Impact Journals, LLC